Identification of a Novel Clinical Phenotype of Severe Malaria using a Network-Based Clustering Approach.

Scientific Reports
Ornella CominettiCliment Casals-Pascual

Abstract

The parasite Plasmodium falciparum is the main cause of severe malaria (SM). Despite treatment with antimalarial drugs, more than 400,000 deaths are reported every year, mainly in African children. The diversity of clinical presentations associated with SM highlights important differences in disease pathogenesis that often require specific therapeutic options. The clinical heterogeneity of SM is largely unresolved. Here we report a network-based analysis of clinical phenotypes associated with SM in 2,915 Gambian children admitted to hospital with Plasmodium falciparum malaria. We used a network-based clustering method which revealed a strong correlation between disease heterogeneity and mortality. The analysis identified four distinct clusters of SM and respiratory distress that departed from the WHO definition. Patients in these clusters characteristically presented with liver enlargement and high concentrations of brain natriuretic peptide (BNP), giving support to the potential role of circulatory overload and/or right-sided heart failure as a mechanism of disease. The role of heart failure is controversial in SM and our work suggests that standard clinical management may not be appropriate. We find that our clustering can be...Continue Reading

References

Sep 1, 1967·Psychometrika·S C Johnson
May 25, 1995·The New England Journal of Medicine·K MarshN Peshu
Sep 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D WallerP A Holloway
Nov 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·M EnglishK Marsh
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·B Novak, J J Tyson
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
Sep 2, 2000·Pediatrics in Review·A D Wolf, J E Lavine
Mar 2, 2002·Science·Hiroaki Kitano
Nov 12, 2002·Nature Medicine·Christopher D ReiterMark T Gladwin
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
May 10, 2006·PLoS Medicine·Andrew C AhnRussell S Phillips
May 11, 2006·PLoS Medicine·Andrew C AhnRussell S Phillips
Aug 30, 2008·Current Opinion in Infectious Diseases·J Brice WeinbergDonald L Granger
May 26, 2009·Nature Genetics·Muminatou JallowUNKNOWN Malaria Genomic Epidemiology Network
Oct 14, 2009·BMC Bioinformatics·Andy D Perkins, Michael A Langston
Jul 29, 2010·The Journal of Infectious Diseases·Jacqueline J JankaDonald J Krogstad
Nov 9, 2010·JAMA : the Journal of the American Medical Association·Steve M TaylorJonathan J Juliano
May 28, 2011·The New England Journal of Medicine·Kathryn MaitlandUNKNOWN FEAST Trial Group
Jun 11, 2011·Malaria Journal·Johanna HerrJakob P Cramer
Aug 9, 2012·Chest·Walter R J TaylorArjen M Dondorp
Jan 29, 2018·PeerJ. Computer Science·Daniel Alcaide, Jan Aerts

❮ Previous
Next ❯

Methods Mentioned

BETA
PCA
SMA

Software Mentioned

Stata
sPCA
R
Matlab

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.